Prolog Ventures

News, insights, analysis and data

Prolog Ventures overview

Stories about Prolog Ventures

Picture of the Company

Skincare brand BioClarity nabs $13 mln

San Diego-based BioClarity, a skincare brand, has secured $13 million in funding. Prolog Ventures led the round.

Picture of the Company

Skincare brand BioClarity nabs $13 mln

San Diego-based BioClarity, a skincare brand, has secured $13 million in funding. Prolog Ventures led the round.

Picture of the Company

CareDox raises $2.8 mln in seed funding

New York-based CareDox, a provider of a digital healthcare platform for K-12 schools, has raised $2.8 million in seed-stage funding led by TEXO Ventures and Prolog Ventures. The company also secured a $1.5 million venture debt agreement with Western Technology Investment. CareDox has now raised $6.9 million in total debt and equity.

Picture of the Company

EndoStim Raises $6 Million

EndoStim Inc., a St Louis-based developer of minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, has raised $6 million in Series B funding. Santé Ventures led the round, and was joined by Prolog Ventures, Vectis Healthcare & Life Sciences Fund and individual angels.

Picture of the Company

Divergence Raises $11.8 Million

Divergence Inc., a St. Louis-based biotech focused on genomics and informatics related to agriculture and infectious disease, has raised $11.8 million in third-round funding. MidPoint Food and Ag Fund LP led the round, and was joined by Prolog Ventures. www.divergence.com

Prolog Ventures funds managed

Closed funds: 5

FundFund sizeClose dateStrategy
Fund sizelock image----------
Close dateFeb 2018
Strategylock image------
Fund sizelock image---------
Close date-
Strategylock image------
Fund sizelock image-------
Close date-
Strategylock image-----

Stories that mention Prolog Ventures

Benson Hill lands $150m in Wheatsheaf and GV-led Series D

St. Louis, Missouri-based Benson Hill, a food innovation engine, has secured US$150 million in Series D funding.

Grooming tech to keep hospitals clean

A bevy of start-ups in recent years have emerged to help disinfect all aspects of hospitals, from handwashing to patient rooms to healthcare devices. This seemed like a novel idea before covid-19, but it’s essential now.

Kinnos nabs $6m

Brooklyn, New York-based Kinnos, an infection prevention company, has secured $6 million in funding.

Sparkling water Spindrift takes in $20 mln

Newton, Massachusetts-based Spindrift, a sparkling water made with real fruit, has raised $20 million in funding. VMG Partners led the round with participation from other investors that included Prolog Ventures, KarpReilly and RiverPark Ventures.

Spindrift attracts $10 mln

Waltham, Massachusetts-based Spindrift, a sparkling water made with real fruit, has raised $10 million in funding. VMG Partners led the round with participation from other backers that included Prolog Ventures and Karp Reilly.

Benson Hill Biosystems rakes in $25 mln Series B

St. Louis, Missouri-based Benson Hill Biosystems, an agricultural tech company, has raised $25 million in Series B funding. Lewis & Clark Ventures and Prelude Ventures led the round with participation from other investors that included Fall Line Capital, S2G Ventures, Alexandria Venture Investments, Cultivation Capital, iSelect Fund, Mercury Fund, Middleland Capital, Missouri Technology Corporation, Prolog Ventures and TechAccel. In conjunction with the funding, David Russell of Lewis & Clark Ventures and Mark Cupta of Prelude Ventures have been added to Benson Hill's board of directors.

CareDox nabs $6.4 mln Series A

New York City-based CareDox, a company that "improves children's health with technology by efficiently connecting schools, families, and healthcare providers," has raised $6.4 million in Series A funding. Digitalis Ventures led the round with participation from First Round Capital, Giza Venture Capital, TEXO Ventures and Prolog Ventures.

VC-backed EndoStim pulls IPO

According to an SEC filing, St.Louis, Missouri and Netherlands-based EndoStim, which focuses on treating acid reflux, has withdrawn its planned IPO. The reason given was "market conditions." Its backers include Santé Ventures, Prolog Ventures and Vectis Healthcare & Life Sciences Fund.